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Abstract

Background: HLA supertypes are groups of functionally related alleles that present
structurally similar antigens to the immune system. Despite many reports of HLA
allele associations with dengue, there have to date been no studies of HLA supertype
associations with disease.
Objectives: To analyse HLA class I supertypes in hospitalised Thai children with
acute dengue illness.
Methods: 762 patients and population-matched controls recruited predominantly in
Bangkok were HLA-A and –B typed. HLA supertype frequencies were compared and
tested for significant dengue disease associations using logistic regression analyses.
Final multivariable models were built by conducting forward stepwise selection
procedures.
Results: In the final logistic regression model, the HLA-B44 supertype was protective
against dengue hemorrhagic fever (DHF) in secondary infections (OR=0.46,
95%CI=0.30-0.72), while the HLA-A02 supertype (OR=1.92, 95%CI=1.30-2.83) and
the HLA-A01/03 supertype (OR=3.01, 95%CI=1.01-8.92) were associated with
susceptibility to secondary dengue fever. The B07 supertype was associated with
susceptibility to secondary DHF in the univariate analysis (OR=1.60, 95%CI=1.052.46), whereas that was not retained in the final model.
Conclusions: As the HLA-B44 supertype is predicted to target conserved epitopes in
dengue, our results suggest that B44 supertype-restricted immune responses to highly
conserved regions of the dengue proteome may protect against secondary DHF.
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Introduction

In mainland southeast (SE) Asia all four dengue virus (DENV) serotypes are in
seasonal circulation. Epidemiologic studies indicate DENV is amplifying in large
population-dense and ethnically-diverse urban centres, such as Bangkok [1]. Here
host immunologic pressure exerts positive selection on DENV [2], before the fittest
serotypic strains spread from urban centres out in cyclical waves across the region
into adjacent populations [1]. Clinical symptoms range from relatively benign dengue
fever (DF) to the more severe dengue hemorrhagic fever (DHF) and dengue shock
syndrome (DSS) [3,4], the latter two conditions associating with a more intense yet
transient viremia [4,5]. Both primary and secondary DENV infections can induce
clinical illness, but most patients with DHF are undergoing secondary infection with a
virus serotype different from prior exposures [6]. Thus, immunologic priming to
DENV influences disease expression, the level of viremia, and in turn the selection
and transmission of the fittest viral strains.

The immunologic function of class I human leukocyte antigens (HLA-A, B and C) is
to present degraded fragments of endogenously synthesised virus antigens to CD8+ T
cells of the adaptive immune response [7]. Some HLA class I molecules are also
recognised by natural killer (NK) cells that have an innate ability to recognize and
destroy infected cells [8]. HLA class I genes are extremely polymorphic and encode
thousands of alleles, the majority of which are distinct structural and functional
variants (see http://www.ebi.ac.uk/imgt/hla). Most polymorphism affects specific
amino acids forming a series of pockets (A-F) which accommodate virus-derived
peptides in the class I antigen-binding cleft, thus influencing the types of antigens
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presented to T cells [9]. Nevertheless, analysis of the protein sequence of antigens
bound by different HLA class I molecules has identified groups of alleles or
“supertypes”, with a common preference to present short peptides or antigen
“supermotifs” sharing a similar structure [10].

The frequency of HLA class I alleles and combinations of alleles in linkage
disequilibrium or haplotypes varies considerably between different ethnic groups [11,
12, see http://www.allelefrequencies.net]. Analysis of HLA class I allele and
haplotype profiles in ethnic Thais has shown that this population is highly
representative of the genetic admixture present in mainland SE Asians [12,13]. Casecontrol HLA association studies with dengue disease have been performed in various
cohorts identified in mainland SE Asia [14]. Collectively, nearly 1600 dengue patients
have been HLA typed in Thailand [15, 16, 17], Vietnam [18, 19] and Malaysia [20].
Studies in ethnic Thais have indicated that a variety of HLA class I allele associations
occur with secondary DENV infections, in particular with the HLA-B locus [16, 17]
which

is

the

most

polymorphic

in

the

human

genome

(see

http://www.ebi.ac.uk/imgt/hla) and is also consistent with previous observations that
HLA-B dominates the immune response to DENV and other RNA viruses [21-23].

To date, there have been no reports of any HLA class I supertype associations with
dengue disease. Nevertheless, bioinformatic modelling of the dengue proteome for
predictive HLA class I binding antigen supermotifs has been performed [23]. In this
study, we have HLA typed just over 750 ethnic Thai dengue patients and controls, and
stratified the detected HLA class I alleles into their respective supertype groups.
Using logistic regression analyses, we have identified a variety of HLA class I
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supertype associations with dengue disease severity and susceptibility, and discuss
our observations in the context of previous case control association studies and
computational analyses of HLA supermotifs in the DENV proteome.
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Materials and Methods

Patients and controls. Unrelated hospitalised ethnic Thai children with serologically
and virologically confirmed DENV infections between the ages of 3 and 14 years and
weighing > 20 Kg were enrolled in Bangkok with fully informed consent between
1994-2007, as previously described [16]. Clinical diagnoses of DF and DHF were
assigned by an expert physician reviewer guided by the 1997 World Health
Organisation (WHO) criteria [3]. 277 DF and 163 DHF patients were available for
HLA supertype analysis. 152 of these patients had been included in a previous HLA
allele association study [16]. DHF was further classified into increasing grades of
clinical severity, namely DHF-1, -2, -3 and -4 according to WHO criteria [3].
Serological responses to DENV were measured by both enzyme immunoassay and
hemagglutination inhibition test. DENV serotypes (DENV-1, -2, -3 and -4) were
identified by isolation in Toxorhynchites splendens mosquitoes or RT-PCR, as
previously described [4, 5]. The infecting DENV serotype was determined in all but 7
patients. Primary or secondary infections were defined on the basis of DENV-specific
IgM:IgG serum antibody ratios and the titer of hemagglutination inhibition antibodies,
according to WHO guidelines [3]. On this basis, 77/277 (27.8%) DF patients had
primary infections, 200/277 (72.2%) DF patients had secondary infections, 13/163
(8.0%) DHF patients had primary infections and 150/163 (92.0%) DHF patients had
secondary infections. Two hundred and twenty-seven unrelated, ethnically and
geographically matched, normal healthy Thai blood donors with no clinical history of
autoimmune or malignant disease, whose families were known to have resided in the
Bangkok metropolitan area for many generations, were used as population controls.
However, the previous exposure to DENV in this control group was unknown. A
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further 95 unrelated Thai patients (aged 3-14 years), composed of 51 secondary DF
and 44 secondary DHF patients enrolled in Kamphaeng Phet (located 320km
northwest of Bangkok) [4], were used to test and confirm the major HLA-B44
supertype association identified in the Bangkok patients. All of the Kamphaeng Phet
patients were included in a previous HLA allele association study [16]. No
geographically-matched blood donor controls for the Kamphaeng Phet population
were available.

HLA-A and –B typing and supertype determination. Both serological phenotyping of
fresh peripheral blood lymphocytes and molecular genotyping of full length genomic
DNA, using PCR with sequence-specific primers and direct sequencing, were
performed

to HLA

type patients

and

controls,

as

previously described

[12,16,17,24,25]. This enabled confirmation of HLA class I allele expression and the
exclusion of null or un-expressed alleles, before HLA-A and –B alleles were assigned
according to Marsh et al [26] and supertypes according to Sidney et al [10]. HLA
supertype frequencies (SF%) were determined using the following formula; SF (%) =
n/N x 100, where n = the number of individuals with a given supertype and N = the
total number of individuals supertyped in each of the patient and control groups.

Study design and statistical analysis. HLA-A and B SF’s were compared between
each patient group (stratified for primary or secondary infections, disease severity, or
the infecting DENV serotype) and the controls, and tested for associations using the
Wald ChiSquare test for heterogeneity (2 x 2 contingency tables). P values < 0.05
were considered significant. Correction of P values (Pc) for multiple comparisons
(Bonferroni’s) and random supertype associations was dependent on the number and
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type of comparisons made; namely the number of HLA-A (n=7) or -B (n=7)
supertypes identified, combined with the number of patient and control group
comparisons (n=7, primary DF versus controls, secondary DF versus controls,
secondary DHF versus controls, all secondary infections versus controls, primary DF
versus secondary DF, primary DF versus secondary DHF, secondary DF versus
secondary DHF), which equates to 7 + 7 or 14 comparisons. Pc values < 0.05 were
considered highly significant. Odds ratio (OR) with 95% confidence interval (CI) was
used to assess the risk of either disease severity (OR with 95% CI >1.0) or protection
(OR with 95% CI <1.0), associated with specific supertypes in either primary or
secondary DENV infections. Previous (a priori) power calculations demonstrated that
all patient and control groups were of sufficient size to achieve at least 80% power to
detect HLA class I supertype differences of 11-21% (P< 0.05) [17], except for the
primary DHF group (n=13) which was under powered and thus deemed too small for
inclusion in the analysis.

Multivariable regression models were also created to address the adjusted relationship
between the clinical outcome of primary or secondary DENV and HLA class I
supertype. Dengue infection status was classified into three clinical types (primary
DF, secondary DF, and secondary DHF) and the relationship between risk of each
clinical phenotype versus no disease (control) and HLA supertype was quantified
using three separate logistic regressions. A forward stepwise selection procedure was
performed to select each final multivariable model. All HLA class I supertypes were
evaluated for inclusion in the multivariable model and retained if the P-value for an
HLA supertype was <0.05. In order to assess whether the presence of one HLA
supertype modified the relationship between another HLA supertype and risk of
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specific dengue clinical outcomes, two-way interaction terms were tested for
supertypes retained in the final model.
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Results

HLA-A supertypes. Our analysis of a Bangkok cohort of hospitalised paediatric
dengue patients revealed a moderately significant association between the A02
supertype and susceptibility to secondary DF and DHF, compared to the ethnically
and geographically matched controls (Table 1). The preferred supermotif amino-acids
held in the B and F pockets of the HLA class I antigen binding clefts of A02
supertype alleles, together with the A02 supertype alleles identified in our Thai cohort
are also given in Table 1.

HLA-B supertypes. In the equivalent analysis of HLA-B supertypes we detected
another modest association between the B07 supertype and susceptibility to DHF in
patients with secondary infections in Bangkok (Table 2). By contrast, the most
significant association detected was with the B44 supertype and protection against
developing severe DHF in secondary DENV infections, when compared to secondary
DF patients and the controls (Pc < 0.05, Table 2). This association was tested in a
second cohort of hospitalised Thai children with DENV infections identified in a
geographically distinct region (Kamphaeng Phet, Thailand). The frequency of the B44
supertype in Kamphaeng Phet secondary DHF (12/44, 27.3%) was also significantly
reduced compared to secondary DF (24/51, 47.1%) in the same location (Wald Chi
Square = 3.9, P = 0.0497, OR = 0.422, 95% CI 0.178-0.999).

Logistic regression model. To investigate whether the evaluated HLA class I
supertypes were related to either increased or decreased risk of primary/secondary DF
or secondary DHF versus controls, logistic regression models were built (Table 3).
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The primary DF model did not retain any significant supertype associations.
However, the secondary DF model showed that A02 (OR = 1.92; P = 0.0011) and
A01/A03 (OR = 3.01; P = 0.0474) supertypes were related to increased risk of
secondary DF. The secondary DHF model demonstrated that the B44 supertype was
related to decreased risk of secondary DHF (OR = 0.46; P = 0.0007). Separate models
predicting secondary DF that included two-way interactions between A02 with
A01/A03, A02 with B44, B07 with B44, and A01/A03 with B44, did not demonstrate
significant interactions between these HLA class I supertype combinations,
suggesting the presence of one did not significantly modify or change the relationship
of the other supertype to secondary DF and DHF.

B44 supertype protects against secondary DHF with all four DENV serotypes.
Stratification for the known infecting DENV serotype indicated that the B44
supertype was reduced in frequency in secondary DHF patients infected with any of
the four serotypes (Table 4). This trend reached significance only in the DENV-1
secondary infection group, which was the largest of the stratified groups (Table 4).

B44 supertype protects against the most severe forms of DHF. Our analysis of
Bangkok DHF patients stratified for increasing disease severity according to WHO
classification of DHF grades 1, 2, 3 and 4 [3], indicated that the B44 supertype
associates with protection against the more severe forms of DHF-2 and DHF-3/4
(Table 5). The most frequent B44 supertype-related alleles in our Thai cohort were
HLA-B*40, B*18 and B*44, which were all relatively reduced in frequency in the
secondary DHF patients (13.0%, 6.5% and 5.2%, respectively) compared to the
equivalent antigen or phenotype frequencies in the controls (21.1%, 11.5% and
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11.9%, respectively). This indicates that the B44 supertype associations described in
Tables 2-5 are not due to relatively increased or decreased frequencies of any
particular B44-related allele.
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Discussion

The largest HLA gene association studies with dengue have been performed in
mainland SE Asian populations [reviewed in 14]. A variety of HLA-A and –B locus
alleles have been reported to associate with protection or susceptibility to various
clinical manifestations of DENV infection. Some of these associations have been
consistent across Thai [15, 16, 17], Vietnamese [18, 19] and Malaysian populations
[20], while other associations have been either target population- or DENV serotypespecific. Such intra-regional differences in HLA associations with dengue may reflect
the cyclical dynamics of distinct epidemic foci in the most population-dense urban
centres such as Bangkok and Ho Chi Minh City that are not necessarily in the same or
synchronized DENV transmission zones. Moreover, given the genetic similarity of
ethnic Thais and Vietnamese in terms of their HLA allele profiles [12, 13, see
http://www.allelefrequencies.net], any apparent regional differences of HLA
associations with dengue may also reflect variations in historic immunologic priming
to disparate DENV serotypes. Nevertheless, HLA class I allele associations have been
reported in a variety of other populations in south Asia and the Americas [reviewed in
14], which indicates that the clinical outcome of secondary exposure to DENV is at
least in part mediated by T and NK cell-driven immune responses restricted by some
HLA alleles.

Bioinformatic scanning of the DENV proteome for HLA binding antigen supermotifs
has predicted that most class I supertypes target predominantly non-conserved regions
of the virus [23]. Cross-reactive partial immunity to previously unseen DENV
serotypes is a recognised feature of the T cell response to DENV in secondary
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infections [27], and may relate to HLA class I presentation of DENV epitopes that are
not conserved across all four DENV serotypes. By contrast, the B44 supertype is
predicted to target conserved regions of the DENV proteome [23]. In particular HLAB*40:01 and B*18:01, which are relatively common B44 supertype alleles in ethnic
Thais [28, see http://www.allelefrequencies.net], are considered most efficient at
targeting conserved regions across the proteomes of all four DENV serotypes [23].
HLA-B*40 has also been associated with relatively high magnitude T cell responses
to DENV in Sri Lankans (22). Thus, the protective associations we describe in Tables
2-5 may reflect HLA-B44 supertype-restricted T cell responses in immunologically
primed patients targeting highly conserved DENV proteins and effectively reducing
the chance of severe complications of secondary DENV infections arising. Reduced
frequencies of HLA-B44 supertype-related alleles have also been reported in
Malaysian DHF patients [20]. Moreover, given that the HLA class I supertypes in our
patient groups were compared against the equivalent supertype frequencies in the
ethnically and geographically matched urban population controls that are most likely
to have had historic exposure to DENV, the relative protective effect of the B44
supertype may even be stronger if compared against subclinical or asymptomatic
controls.

The concept of HLA supertypes is based on extensive information derived from either
peptide binding studies to different HLA class I allelic products [10,29] or from
sequencing natural HLA class I ligands by mass spectrometry [30]. Some
discrepancies exist between these two approaches in defining the precise specificities
of the preferred peptides recognised by different class I supertypes. Nevertheless, both
methods have effectively confirmed that all B44 supertype alleles share a common
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preference for antigenic supermotifs with a negatively charged amino acid (mostly
Glu) in the first anchor position (pos 2) which binds the B-pocket, and a variety of
hydrophobic residues at the C-terminus of the antigenic peptides (pos 9/10, see Table
2) which bind the F-pocket of the class I antigen binding groove [9,10,29,30].
Bioinformatic algorithms utilising this information together with other computational
tools that predict intracellular peptide cleavage and antigen transport efficiency, have
been used to screen conserved DENV protein sequences and identify putative B44
supermotifs [23,31]. For example, the DENV NS3 protein which has protease and
helicase functions is relatively rich in acidic or negatively charged amino acids [32].
Bioinformatic screening of NS3 for HLA class I supermotifs has revealed a 13-mer
peptide (256-EIVDLMCHATFT-267) that is highly conserved across DENV-1, -2, -3
and -4 serotypes [31]. This pan-serotype DENV peptide (NS3 256-267) contains at
least 2 potential B44 supermotifs (Asp256 with Ala264, and Glu259 with Phe266).
DENV NS3 256-267 is also predicted to contain other HLA class I and II supermotifs
[31], and was originally shown to be recognized by a serotype cross-reactive HLADP-restricted CD4 T cell clone [33], making it an attractive potential candidate for
inclusion in future vaccines.

Our observation that the A02 supertype is significantly increased in both secondary
DF and DHF patients compared to geographically and ethnically-matched controls
(Table 1), is consistent with other studies conducted at different time points in
Bangkok [15], which has the largest urban population exposed to DENV in mainland
SE Asia. The A02 supertype is largely composed of HLA-A*02 related alleles [10] of
which

456

variants

have

been

identified

worldwide

http://www.ebi.ac.uk/imgt/hla and http://www.allelefrequencies.net].
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[see

Most of the

polymorphism that defines HLA-A*02 alleles is focused on the pockets of the class I
peptide binding groove.

Such variation is likely to restrict which peptides are

preferentially bound and affect the subsequent antigen-specific immune responses
invoked, as different HLA*02 variants have been shown to correlate with either
secondary DF or DHF [16]. Bioinformatic modelling of the DENV proteome has also
predicted the A02 supertype preferentially binds variable sequences of the proteome
that are not conserved between DENV serotypes [23], which would suggest that in
immunologically primed individuals A02-restricted immune responses to disparate
DENV serotypes are less able to control viral replication.

The A24 supertype is composed of just HLA-A*24 related alleles [10], some of which
have been associated with DHF and DSS in Vietnamese populations identified within
or near to Ho Chi Minh city [18,19], the second largest urban epicentre of DENV
transmission in mainland SE Asia. The A24 supertype is also reputed to target
variable sequences of the DENV proteome that are not conserved between DENV
serotypes [23]. In ethnic Thais HLA-A*24 alleles and the A24 supertype are
increased in frequency in secondary DHF patients relative to secondary DF and
controls, although these are trends rather than replicated associations reaching
statistical significance [16] (Table 1). Similarly, the B07 supertype is significantly
associated with susceptibility to secondary DHF (Table 2). However, this effect may
be due to the presence of HLA-B*51 alleles in the B07 supertype which we have
previously shown to associate with DHF in ethnic Thais [16], but did not retain
significance with the final model (Table 3). By contrast, our logistic regression model
did reveal an association between the relatively rare A01/A03 supertype and
protection against secondary DHF (Table 3), which was not identified in our
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univariate analysis (Table 1). The A01/A03 supertype does have subtle differences in
its preferred antigenic supermotifs presented, and is represented by just the HLAA*30 allele in ethnic Thais (Table 1).

A complex picture is emerging of the association of immune response genes and the
role of their products in determining disease outcome of DENV infection, particularly
after secondary exposures in immunologically primed individuals. Specific HLA class
I alleles [15-20], extended haplotypes encoding specific combinations HLA class I
and II alleles [17], cytokine gene polymorphisms [17], MHC class I chain-related
(MIC) gene deletions [17], and now functionally-defined HLA class I supertypes
(Tables 1, 2, 3 and 5), all associate with various aspects of disease outcome after
DENV exposure. This suggests that there is most likely a major concentration of
genes in the human MHC that influence dengue disease expression. Our study
complements previous bioinformatic predictions on the relative immunogenicity of
the DENV proteome by revealing in a major urban transmission zone that the B44
supertype, which is predicted to target immune epitopes highly conserved across all
DENV serotypes [23], is protective against the most severe consequences of
secondary DENV infection (Table 4).

Taken together, these data suggest that

vaccines designed to replicate and enhance B44 supertype-driven immune responses
to DENV may induce protection against severe disease.
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Table 1. HLA-A supertype frequencies in Bangkok Thai dengue patients and controls

HLA

HLA-A

class I

locus

Super-

alleles

Primary

Secondary

type

in Thais

Infection

Infection

A01

Supertype Frequency (SF%)

Recognised supermotif in target antigens

A*01

Pos 2: Small aliphatic (Ala, Thr, Ser,

A*26

Val, Leu, Iso, Met, Gln)

Control

DF

DF

DHF

N=77

N=200

N=150

N=227

n=

n=

n=

n=

(SF)

(SF)

(SF)

(SF)

7

11

14

23

(9%)

(6%)

(9%)

(10%)

36

105

75

85

(47%)

(53%)

(50%)

(37%)

*A,*C

*B,*C

*A,*B,

A*32
Pos 9/10: Aromatic and large
hydrophobic (Phe, Trp, Tyr, Leu, Iso,
Met)
A02

A*02

Pos 2: Small aliphatic (Ala, Thr, Ser,
Val, Leu, Iso, Met, Gln)

Pos 9/10: Aliphatic and small

*C

hydrophobic (Leu, Iso, Val, Met, Gln,
Ala)
A03

A*03

Pos 2: : Small aliphatic (Ala, Thr, Ser,

A*11

Val, Leu, Iso, Met, Gln)

A*31
A*33

Pos 9/10: Basic (Arg, His, Lys)

24

57

149

99

170

(74%)

(75%)

(66%)

(75%)

A24

A*24

Pos 2: Aromatic and aliphatic (Phe, Trp,
Tyr, Leu, Iso, Val, Met, Gln)

32

65

63

82

(42%)

(33%)

(42%)

(36%)

1

11

4

5

(1%)

(6%)

(3%)

(2%)

-

3

3

3

(2%)

(2%)

(1%)

2

4

2

3

(3%)

(2%)

(1%)

(1%)

P=

Pc=

OR

95%CI

0.0019

0.0266

1.85

1.26 - 2.72

0.0161

0.2254

1.67

1.10 - 2.54

0.0010

0.0140

1.77

1.26 - 2.49

Pos 9/10: Aromatic, aliphatic and
hydrophobic (Phe, Try, Tyr, Leu, Ile,
Met, Val, Ala)
A01/

A*30

A03

Pos 2: Small and aliphatic (Ala, Thr,
Ser, Val, Leu, Iso, Met, Gln)

Pos 9/10: Aromatic and basic (Tyr, Arg,
Lys)
A01/

A*29

A24

Pos 2: Small, aliphatic and aromatic
(Ala, Ser, Thr, Val, Leu, Ile, Met, Gln,
Phe, Trp, Tyr)

Pos 9/10: Aromatic and large
hydrophobic (Phe, Trp, Tyr, Leu, Iso,
Met)
UC

Unknown

A*34

Wald Chi Square (WCSq)
*A A2 SF% in secondary DF infections vs controls,
WCSq=9.7
*B A2 SF% in secondary DHF infections vs controls,
WCSq=5.8
*C A2 SF% in all secondary infections (DF and DHF) vs
controls, WCSq=10.8

HLA-A supertypes were designated according to Sidney et al [10] and are given
together with their known target antigen supermotifs. HLA-A alleles detected in ethnic
25

Thais (patients and controls) and known to be in defined supertype groups [10], are as
given. The 2-digit HLA allele designations indicate that all related class I alleles
detected in the Thai population [28] fall within the defined supertype group. Within the
respective supermotifs the amino-acid at position 2 (pos 2) binds to the B pocket, and
amino-acids at pos 9 or 10 bind specifically to the F pocket of the HLA class I antigenbinding groove [9,10]. N = total number of individuals in either patient or control
groups, n = number of patients or controls with given HLA-A supertype. HLA-A class
I supertype frequencies (SF) are given in parentheses and expressed as a relative
percentage of the respective patient and control groups. SF showing significant
differences between patient and control groups is indicated by an asterisk. Wald Chi
Square, P values, Bonferroni’s corrected P values (Pc), Odds Ratio (OR) and 95%
Confidence Interval (CI) are given in the last 4 rows. Significant P and Pc values, OR
and 95% CI are given in bold. Pc for *A, *B, *C = P x 14 (7 supertypes + 7 patient
group and control comparisons). 13 patients were identified with primary DHF but
were excluded from the supertype analysis due to the relatively low numbers and lack
of statistical power in testing for associations in this group (see Materials and
Methods).
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Table 2. HLA-B supertype frequencies in Bangkok Thai dengue patients and controls

HLA

HLA-B

class I

locus

Super-

alleles

Primary

Secondary

type

in Thais

Infection

Infection

B07

B*07

Recognised supermotif in target

Supertype Frequency (SF%)

antigens

Pos 2: Proline

B*35
B*51

Pos 9/10: Aromatic, aliphatic and

B*54

hydrophobic (Phe, Try, Tyr, Leu, Ile,

B*55

Met, Val, Ala)

Control

DF

DF

DHF

N=77

N=200

N=150

N=227

n=

n=

n=

n=

(SF)

(SF)

(SF)

(SF)

27

76

64

72

(35%)

(38%)

(43%)

(32%)

*B

*A,*B

*A,*B

2

-

3

B*56
B*67
B08

B*08

Pos 2: undefined

-

(1%)

(1%)

Pos 9/10: Aromatic, aliphatic and
hydrophobic (Phe, Try, Tyr, Leu, Ile,
Met, Val, Ala)
B27

B*27

Pos 2: Basic (Arg, His, Lys)

13

27

50

35

48

B*38
B*39

Pos 9/10: Aromatic, aliphatic, basic and

B*48

hydrophobic (Phe, Try, Trp, Leu, Ile,

(17%)

(25%)

(23%)

(21%)

29

80

40

100

(38%)

(40%)

(27%)

(44%)

*C,*E

*C,*D,

*D,*E

Met, Arg, His, Lys, Val, Ala)

B44

Pos 2: Acidic (Asp, Glu)

B*18
B*37

B58

B*40

Pos 9/10: Aromatic, aliphatic and

B*44

hydrophobic (Phe, Trp, Tyr, Leu, Ile,

B*50

Val, Met, Gln, Ala)

B*15:17

Pos 2: Small (Ala, Ser, Thr)

B*57

*E

12

24

28

40

(16%)

(12%)

(19%)

(18%)

43

95

77

121

(56%)

(48%)

(51%)

(53%)

13

36

24

31

(17%)

(18%)

(16%)

(14%)

P=

Pc=

OR

95% CI

0.0307

0.4298

Pos 9/10: Aromatic, aliphatic and

B*58

hydrophobic (Phe, Trp, Tyr, Leu, Ile,
Val, Met, Gln, Ala)
B62

B*15:01

Pos 2: Aliphatic (Leu, Iso, Val, Met,

B*15:02

Gln)

B*15:12
B*15:13

Pos 9/10: Aromatic, aliphatic and

B*15:25

hydrophobic (Phe, Trp, Tyr, Leu, Ile,

B*46

Val, Met, Gln, Ala)

B*52
UC

Unconfirmed

B*13
B*15:21
B*15:27
B*15:32

Wald Chi Square (WCSq)
*A B07 SF% in secondary DHF infections vs controls,
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1.60

1.05 - 2.46

WCSq = 4.7
*B B07 SF% in all secondary infections (DF and DHF) vs

0.0442

0.6188

1.44

1.01 – 2.04

0.0097

0.1358

0.55

0.35 - 0.86

*D B44 SF% in secondary DHF vs controls, WCSq = 11.5

0.0007

0.0098

0.46

0.30 - 0.72

*E B44 SF% in all secondary infections (DF and DHF) vs

0.0185

0.2590

0.66

0.47 - 0.93

controls, WCSq = 4.0
*C B44 SF% in secondary DHF vs secondary DF infections,
WCSq = 6.7

controls, WCSq = 5.5

HLA-B supertypes were designated according to Sidney et al [10] and are given
together with their known target antigen supermotifs. HLA-B alleles detected in ethnic
Thais and known to be in defined supertype groups [10], are as given. The 2-digit HLA
allele designations indicate that all related class I alleles detected in the Thai
population [28] fall within the defined supertype group. Within the respective
supermotifs the amino-acid at pos 2 binds the B pocket, and amino-acids at pos 9 or 10
bind specifically to the F pocket of the HLA class I antigen-binding groove [9,10]. N =
total number of individuals in either patient or control groups, n = number of patients
or controls with given HLA-B supertype. HLA-B class I supertype frequencies (SF)
are given in parentheses and expressed as a relative percentage of the respective patient
and control groups. SF showing significant differences between patient and control
groups are indicated by an asterisk. Wald Chi Square, P values, Bonferroni’s corrected
P values (Pc), Odds Ratio (OR) and 95% Confidence Interval (CI) are given in the last
6 rows. Significant P and Pc values, OR and 95% CI are given in bold. Pc for *A, *B,
*C, *D and *E = P x 14 (7 supertypes + 7 patient group and control comparisons). 13
patients were identified with primary DHF but were excluded from the supertype
analysis due to the relatively low numbers and lack of statistical power in testing for
associations in this group (see Materials and Methods).
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Table 3. Logistic regression models for HLA class I supertype associations with
dengue virus infection

OR
Secondary DENV
HLA class I Supertype versus

95% CI

P value

Infection
Controls
A02

1.92

1.30 – 2.83

0.0011

A01/A03

3.01

1.01 – 8.92

0.0474

B44

0.46

0.30 – 0.72

0.0007

DF

DHF

OR = Odds Ratio; 95% CI = 95% Confidence Interval.
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Table 4. Logistic regression analysis of HLA-B44 supertype frequencies in secondary

DENV-1, DENV-2, DENV-3 or DENV-4 infections in Bangkok Thais

DENV serotype identified in secondary infections
DENV-1

HLA B44 Supertype

OR (95%CI)

DENV-2

DENV-3

DENV-4

Control

DF

DHF

DF

DHF

DF

DHF

DF

DHF

N=74

N= 50

N=40

N=39

N=42

N=37

N=42

N=21

N=227

n=

n=

n=

n=

n=

n=

n=

n=

n=

(SF)

(SF)

(SF)

(SF)

(SF)

(SF)

(SF)

(SF)

(SF)

32

12

14

11

18

11

15

5

100

(43%)

(24%)

(35%)

(28%)

(43%)

(30%)

(36%)

(24%)

(44%)

0.97

0.40

0.68

0.50

0.95

0.54

0.71

0.40

Patient Groups versus

(0.57-

(0.20-

(0.34-

(0.24-

(0.49-

(0.25-

(0.36-

(0.14-

Controls (ref)

1.64)

0.81)*

1.38)

1.05)

1.85)

1.14)

1.40)

1.12)

0.9031

0.0105

0.2877

0.0675

0.8862

0.1056

0.3172

0.0809

ref

0.41

Wald Chi Square
derived P value
OR (95%CI)
DHF versus DF (ref)

ref

0.73

ref

0.56

ref

0.56

within given DENV

(0.19-

(0.28-

(0.22-

(0.17-

serotype

0.92)*

1.89)

1.43)

1.84)

0.0300

0.5168

0.2291

0.3419

Wald Chi Square
derived P value

The HLA B44 supertype was designated according to Sidney et al [10] and the known
target antigen supermotif is as given in Table 2. Secondary DF and DHF patients were
stratified for infecting dengue virus serotype as described in Materials and Methods.
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ref

N = total number of individuals in each patient and control group, n = number of
patients with HLA-B44 supertype. HLA-B44 supertype frequencies (SF) are given in
parentheses and expressed as a relative percentage of the respective patient and
control groups in row 1. The infecting virus serotype was not determined in two
patients with secondary DF and three patients with secondary DHF (as given in Table
2). Of these patients with an undetermined dengue serotype two had the B44
supertype, one with secondary DF and the other with secondary DHF . Odds Ratios
(OR) with 95% confidence interval (95% CI) were generated using multivariable
logistic regression. OR (95%CI) generated for comparisons of SF in patient groups
versus controls (ref) are given in row 2. OR (95%CI) generated for comparisons of SF
in DHF versus DF (ref) in patients infected with the same DENV subtype are given in
row 3. * OR showing significant B44 SF differences between patient and control
groups are indicated in bold and with an asterisk. Significant Wald Chi Square
derived P values (<0.05) are given in bold.
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Table 5. Logistic regression analysis of HLA B44 supertype associations with severe
secondary dengue infections in Bangkok Thais

HLA-B44 Supertype Frequency (SF%) in patients with secondary
dengue and controls

HLA B44 Supertype

Secondary

Secondary

Secondary

Secondary

DF

DHF-1

DHF-2

DHF-3/4

N=200

N= 22

N= 96

N= 32

N=227

n=

n=

n=

n=

n=

(SF)

(SF)

(SF)

(SF)

(SF)

80

7

28

5

100

(40%)

(32%)

(29%)

(16%)

(44%)

0.85

0.59

0.52

0.24

Ref

Control

OR
(95%CI)
Patient Groups versus
controls (ref)

(0.58-1.25) (0.23-1.51) (0.31- 0.87)* (0.09-0.63)*

Wald Chi Square derived
P value

0.3975

0.2727

0.0131

0.0041

Ref

0.70

0.62

0.28

OR
(95%CI)
DHF versus DF (ref)

(0.27-1.79) (0.37-1.04) (0.10-0.75)*

Wald Chi Square derived
P value

0.4574
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0.0711

0.0117

HLA-B44 supertypes were designated according to Sidney et al [10] and the known
target antigen supermotif is as given in Table 2. Secondary DHF patients were
stratified for disease severity into DHF-1, -2 and -3/4 groups as described in Materials
and Methods. Only one patient in the DHF-3/4 group was defined as DHF-4. N = total
number of individuals in each patient and control group, n = number of patients with
HLA-B44 supertype. HLA-B44 supertype frequencies (SF) are given in parentheses
and expressed as a relative percentage of the respective patient and control groups in
row 1. Odds Ratios (OR) with 95% confidence interval (95% CI) were generated
using multivariable logistic regression. OR (95%CI) generated for comparisons of SF
in patient groups versus controls (ref) are given in row 2. OR (95% CI) generated for
comparisons of SF in DHF versus DF (ref) are given in row 3. * OR showing
significant B44 SF differences between patient and control groups are indicated in
bold and with an asterisk. Significant Wald Chi Square derived P values (<0.05) are
given in bold.
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